Save information for later
Sign Up

Learn About Dyserythropoietic Anemia and Thrombocytopenia

View Main Condition: Anemia

What is the definition of Dyserythropoietic Anemia and Thrombocytopenia?

Dyserythropoietic anemia and thrombocytopenia is a condition that affects blood cells and primarily occurs in males. A main feature of this condition is a type of anemia called dyserythropoietic anemia, which is characterized by a shortage of red blood cells. The term "dyserythropoietic" refers to the abnormal red blood cell formation that occurs in this condition. In affected individuals, immature red blood cells are unusually shaped and cannot develop into functional mature cells, leading to a shortage of healthy red blood cells. People with dyserythropoietic anemia and thrombocytopenia can have another blood disorder characterized by a reduced level of circulating platelets (thrombocytopenia). Platelets are cells that normally assist with blood clotting. Thrombocytopenia can cause easy bruising and abnormal bleeding. While people with dyserythropoietic anemia and thrombocytopenia can have signs and symptoms of both blood disorders, some are primarily affected by anemia, while others are more affected by thrombocytopenia.

What are the causes of Dyserythropoietic Anemia and Thrombocytopenia?

Mutations in the GATA1 gene cause dyserythropoietic anemia and thrombocytopenia. The GATA1 gene provides instructions for making a protein that attaches (binds) to specific regions of DNA and helps control the activity of many other genes. On the basis of this action, the GATA1 protein is known as a transcription factor. The GATA1 protein is involved in the specialization (differentiation) of immature blood cells. To function properly, these immature cells must differentiate into specific types of mature blood cells. Through its activity as a transcription factor and its interactions with other proteins, the GATA1 protein regulates the growth and division (proliferation) of immature red blood cells and platelet-precursor cells (megakaryocytes) and helps with their differentiation.

How prevalent is Dyserythropoietic Anemia and Thrombocytopenia?

Dyserythropoietic anemia and thrombocytopenia is a rare condition; its prevalence is unknown. Occasionally, individuals with this disorder are mistakenly diagnosed as having more common blood disorders, making it even more difficult to determine how many people have dyserythropoietic anemia and thrombocytopenia.

Is Dyserythropoietic Anemia and Thrombocytopenia an inherited disorder?

This condition is inherited in an X-linked pattern. A condition is considered X-linked if the mutated gene that causes the disorder is located on the X chromosome, one of the two sex chromosomes in each cell. In males (who have only one X chromosome), one altered copy of the gene in each cell is sufficient to cause the condition. Because females have two copies of the X chromosome, one altered copy of the gene in each cell usually leads to less severe symptoms in females than in males or may cause no symptoms in females. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.

Who are the top Dyserythropoietic Anemia and Thrombocytopenia Local Doctors?
Experienced in Dyserythropoietic Anemia and Thrombocytopenia
Hematology Oncology | Hematology | Oncology
Experienced in Dyserythropoietic Anemia and Thrombocytopenia
Hematology Oncology | Hematology | Oncology

Administrators Of The Tulane Educational Fund

1415 Tulane Ave, 
New Orleans, LA 
 (4.2 mi)
Languages Spoken:
English
Accepting New Patients

Chancellor Donald is a Hematologist Oncology specialist and a Hematologist in New Orleans, Louisiana. Dr. Donald and is rated as an Experienced provider by MediFind in the treatment of Dyserythropoietic Anemia and Thrombocytopenia. His top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Familial Colorectal Cancer, and Paget Disease of the Breast. Dr. Donald is currently accepting new patients.

Experienced in Dyserythropoietic Anemia and Thrombocytopenia
Family Medicine | Internal Medicine
Experienced in Dyserythropoietic Anemia and Thrombocytopenia
Family Medicine | Internal Medicine

St Joseph Medical Clinic A Medical Corporation

22080 La Hwy 20 W, 
Vacherie, LA 
 (37.0 mi)
Languages Spoken:
English
Accepting New Patients

Raja Talluri is a Family Medicine specialist and an Internal Medicine provider in Vacherie, Louisiana. Dr. Talluri and is rated as an Experienced provider by MediFind in the treatment of Dyserythropoietic Anemia and Thrombocytopenia. His top areas of expertise are Necrosis, Generalized Tonic-Clonic Seizure, Sepsis, Gastrostomy, and Endoscopy. Dr. Talluri is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Dyserythropoietic Anemia and Thrombocytopenia
Hematology Oncology
Experienced in Dyserythropoietic Anemia and Thrombocytopenia
Hematology Oncology
608 N Acadia Rd, 
Thibodaux, LA 
 (43.1 mi)
Languages Spoken:
English

James Schweitzer is a Hematologist Oncology provider in Thibodaux, Louisiana. Dr. Schweitzer and is rated as an Experienced provider by MediFind in the treatment of Dyserythropoietic Anemia and Thrombocytopenia. His top areas of expertise are Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Breast Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration.

What are the latest Dyserythropoietic Anemia and Thrombocytopenia Clinical Trials?
The Congenital Dyserythropoietic Anemia Registry (CDAR)

Summary: The investigators propose the creation and maintenance of a comprehensive registry for patients with the diagnosis of Congenital Dyserythropoietic Anemia (CDA) in North America. The goal of this registry will be to collect long-term confidential data on patients with CDA in the US, Canada, and Mexico and create a bio-repository of de-identified patient blood and bone marrow specimens as a tool for...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: October 01, 2014
Published By: National Institutes of Health